Nichd: r & d: supporting the phase IIB clinical trial of subcutaneous levonorgestrel butanoate (LB) for female contraception: non-severable
Active Awarded Last action
- Contract number
- 75N94025F00002
- Awardee
-
Health Decisions, Inc. UEI CMKQYLSLNJG1
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,286,724
Award facts
- Contract value 55% obligated
-
- $1,286,724.00 Current, with exercised options
- $2,355,840.00 Potential, with all options
- Completion date 36% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27713, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $1,053,433 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $233,291 |
About this award
The National Institute of Child Health and Human Development issued a delivery order to Health Decisions, Inc. on August 1, 2025, with a ceiling value of $2.355 million under The Statistical and Clinical Coordinating Center IDIQ to support the Phase IIB clinical trial of subcutaneous levonorgestrel butanoate for female contraception.
The order is set-aside to total small business and carries a cost-plus-fixed-fee pricing structure. Place of performance is Durham, NC. Period of performance extends through December 31, 2028. The work encompasses statistical and clinical coordinating services for this non-severable contraceptive development trial, including protocol finalization, regulatory approval activities, trial start-up coordination, and monitoring and evaluation of clinical outcomes.
Service Contract Inventory reporting for FY2025 reflects $4 thousand invoiced at 0.1 FTEs. Health Decisions self-performed all reported hours with no subcontractors engaged.
Quick answers
Who was awarded contract 75N94025F00002?
75N94025F00002 was awarded to Health Decisions, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2025.
How much is contract 75N94025F00002 worth?
The government has obligated $1,286,724 on 75N94025F00002. Its potential value, with all options, is $2,355,840.
Is contract 75N94025F00002 an order under another contract?
Yes. 75N94025F00002 is a delivery order under 75N94019D00004, an indefinite delivery contract.
Was contract 75N94025F00002 competed?
The extent of competition for 75N94025F00002 was full and open competition after exclusion of sources. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award